Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination with Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients

Project: Research

Project Details

StatusFinished
Effective start/end date11/4/09 → 06/12/14

Funding

  • University of Maryland Baltimore: $22,942.00